Blood cancers

How well do you know your BiTEs from your CAR-Ts?

Sponsored by Amgen Australia Pty Ltd

Speaking at Amgen One, Associate Professor Simon Harrison, Lead for the CAR T-cell Clinical Program at the Peter MacCallum Cancer Centre gave delegates an update on chimeric antigen receptor (CAR) T-cells and bispecific T-cell engagers (BiTEs) for multiple myeloma (MM). “Given the myeloma microenvironment is highly immunoactive, redirecting T-cells to fight the patient’s own cancer ...

Already a member?

Login to keep reading.

© 2021 the limbic